The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women

NCT06556342 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

198

Enrollment

OTHER

Sponsor class

Conditions

Ovary Cancer

Interventions

DRUG: FRD001

Sponsor

Tongji Hospital

Collaborators

[object Object]